Kobayashi Pharmaceutical Co (TSE:4967) Long-Term Capital Lease Obligation : 円577 Mil (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Kobayashi Pharmaceutical Co Long-Term Capital Lease Obligation?

Kobayashi Pharmaceutical Co's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was 円577 Mil.

Kobayashi Pharmaceutical Co's quarterly Long-Term Capital Lease Obligation increased from Sep. 2023 (円533 Mil) to Dec. 2023 (円608 Mil) but then declined from Dec. 2023 (円608 Mil) to Mar. 2024 (円577 Mil).

Kobayashi Pharmaceutical Co's annual Long-Term Capital Lease Obligation increased from Dec. 2021 (円460 Mil) to Dec. 2022 (円531 Mil) and increased from Dec. 2022 (円531 Mil) to Dec. 2023 (円608 Mil).

Kobayashi Pharmaceutical Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for Kobayashi Pharmaceutical Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kobayashi Pharmaceutical Co Long-Term Capital Lease Obligation Chart

Kobayashi Pharmaceutical Co Annual Data

Trend

Mar14

Mar15

Mar16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

682.00

505.00

460.00

531.00

608.00

Kobayashi Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															551.00	539.00	533.00	608.00	577.00

Kobayashi Pharmaceutical Co (TSE:4967) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Kobayashi Pharmaceutical Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Kobayashi Pharmaceutical Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Kobayashi Pharmaceutical Co (TSE:4967) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kobayashi Pharmaceutical Co Ltd (TSE:4967) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

KOY:Germany

Address

KDX Kobayashi Doshomachi Building, 4-4-10 Doshomachi, Chuo-ku, Osaka, JPN, 541-0045

Website

https://www.kobayashi.co.jp

Kobayashi Pharmaceutical Co Ltd is a consumer product company focusing on niche markets. Its portfolio ranges from OTC pharmaceuticals, household products, to body warmers, and skincare. Kobayashi mainly sells its products in drugstores, convenience stores, and general merchandise stores, or GMSes. It has a geographical presence in Japan and is expanding overseas business in the U.S., China, and Southeast Asia.

Kobayashi Pharmaceutical Co (TSE:4967) Headlines

No Headlines